Literature DB >> 15976194

Estrogen-induced abnormal accumulation of fat cells in the rat penis and associated loss of fertility depends upon estrogen exposure during critical period of penile development.

H O Goyal1, T D Braden, C S Williams, P Dalvi, M Mansour, J W Williams.   

Abstract

We previously reported that diethylstilbestrol (DES) or estradiol valerate (EV) exposure at a dose of 0.10-0.12 mg/kg, or higher, per day, on alternate days, from postnatal days 2-12, resulted in abnormal penis development and infertility (H. O. Goyal et al., 2005, J. Androl. 26, 32-43). The objective of this study was to identify a critical developmental period(s) during which EV exposure results in the observed penile abnormalities. Male pups received EV at a dose of 0.10-0.12 mg/kg on postnatal day(s) 1, 1-3, 4-6, 1-6, 7-12, 13-18, 19-24, or 25-30. Fertility was tested at 102-115 days of age and tissues were examined at 117-137 days. Both penile morphology and fertility were unaltered in rats treated with EV after 12 days of age. Conversely, except in rats treated on postnatal day 1 only, none of the males treated prior to 12 days of age sired pups, and all had abnormal penises, including varying degrees of abnormal accumulation of fat cells and loss of cavernous spaces and smooth muscle cells in the corpora cavernosa penis, which were maximal in the 1-6-day group. Also, the preputial sheath was partially released or its release was delayed, and the weight of the bulbospongiosus muscle was significantly reduced. Plasma testosterone (T) in the 1-6- and 4-6-day groups and intratesticular T in the 4-6-day group were significantly lower. The testosterone surge, characteristic of controls in the first week of life, was suppressed in the 1-3-day group. Estrogen receptor alpha mRNA expression was enhanced in the body of the penis in the 1-3-day group, but not in the 13-18-day group. Hence, EV exposure prior to 12 days of age (as short as 1-3 days postnatal), but not after 12 days of age, results in long-term abnormal penile morphology, characterized by abnormal accumulation of fat cells in the corpora cavernosa penis and, consequently, loss of fertility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15976194     DOI: 10.1093/toxsci/kfi233

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  11 in total

1.  Estrogen-induced maldevelopment of the penis involves down-regulation of myosin heavy chain 11 (MYH11) expression, a biomarker for smooth muscle cell differentiation.

Authors:  L A Okumu; Sequoia Bruinton; Tim D Braden; Liz Simon; Hari O Goyal
Journal:  Biol Reprod       Date:  2012-11-08       Impact factor: 4.285

2.  Comparative effects of neonatal diethylstilbestrol on external genitalia development in adult males of two mouse strains with differential estrogen sensitivity.

Authors:  Phitsanu Mahawong; Adriane Sinclair; Yi Li; Bruce Schlomer; Esequiel Rodriguez; Max M Ferretti; Baomai Liu; Laurence S Baskin; Gerald R Cunha
Journal:  Differentiation       Date:  2014-10-16       Impact factor: 3.880

3.  Genetically induced estrogen receptor α mRNA (Esr1) overexpression does not adversely affect fertility or penile development in male mice.

Authors:  John Heath; Yazeed Abdelmageed; Tim D Braden; Carol S Williams; John W Williams; Tessie Paulose; Isabel Hernandez-Ochoa; Rupesh Gupta; Jodi A Flaws; Hari O Goyal
Journal:  J Androl       Date:  2010-10-07

Review 4.  Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction.

Authors:  Abdulmaged M Traish; Irwin Goldstein; Noel N Kim
Journal:  Eur Urol       Date:  2007-02-20       Impact factor: 20.096

Review 5.  Reproductive drugs and environmental contamination: quantum, impact assessment and control strategies.

Authors:  Harpreet Kaur; Madhu Bala; Gulshan Bansal
Journal:  Environ Sci Pollut Res Int       Date:  2018-07-23       Impact factor: 4.223

6.  Mouse hypospadias: A critical examination and definition.

Authors:  Adriane Watkins Sinclair; Mei Cao; Joel Shen; Paul Cooke; Gail Risbridger; Laurence Baskin; Gerald R Cunha
Journal:  Differentiation       Date:  2016-04-05       Impact factor: 3.880

7.  Estrogen-induced developmental disorders of the rat penis involve both estrogen receptor (ESR)- and androgen receptor (AR)-mediated pathways.

Authors:  H O Goyal; T D Braden; C S Williams; J W Williams
Journal:  Biol Reprod       Date:  2009-05-06       Impact factor: 4.285

8.  Mal-development of the penis and loss of fertility in male rats treated neonatally with female contraceptive 17alpha-ethinyl estradiol: a dose-response study and a comparative study with a known estrogenic teratogen diethylstilbestrol.

Authors:  Ensa Mathews; Tim D Braden; Carol S Williams; John W Williams; Olga Bolden-Tiller; Hari O Goyal
Journal:  Toxicol Sci       Date:  2009-09-03       Impact factor: 4.849

9.  Effect of estradiol on penile erection: a cross-sectional study.

Authors:  Zhi-He Xu; Xin-He Xu; Dong Pan; Tong-Yan Liu; Ming-Zhen Yuan; Shan Jiang; Yong Guan; Sheng-Tian Zhao
Journal:  Transl Androl Urol       Date:  2019-12

10.  Activation of Penile Proadipogenic Peroxisome Proliferator-Activated Receptor gamma with an Estrogen: Interaction with Estrogen Receptor Alpha during Postnatal Development.

Authors:  Mahmoud M Mansour; Hari O Goyal; Tim D Braden; John C Dennis; Dean D Schwartz; Robert L Judd; Frank F Bartol; Elaine S Coleman; Edward E Morrison
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.